Literature DB >> 10781524

Macular oedema: the role of soluble mediators.

D Kent1, S A Vinores, P A Campochiaro.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10781524      PMCID： PMC1723483          DOI： 10.1136/bjo.84.5.542

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  62 in total

Review 1.  Experimental autoimmune uveoretinitis: a model system for immunointervention: a review.

Authors:  J V Forrester; J Liversidge; H S Dua; A Dick; F Harper; P G McMenamin
Journal:  Curr Eye Res       Date:  1992       Impact factor: 2.424

2.  Immunohistochemical localization of blood-retinal barrier breakdown sites associated with post-surgical macular oedema.

Authors:  S A Vinores; A Amin; N L Derevjanik; W R Green; P A Campochiaro
Journal:  Histochem J       Date:  1994-08

3.  Blood-eye barriers in the rat: correlation of ultrastructure with function.

Authors:  P A Stewart; U I Tuor
Journal:  J Comp Neurol       Date:  1994-02-22       Impact factor: 3.215

4.  Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor.

Authors:  M B Grant; R N Mames; C Fitzgerald; E A Ellis; M Aboufriekha; J Guy
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

5.  Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium.

Authors:  S A Vinores; E Van Niel; J L Swerdloff; P A Campochiaro
Journal:  Histochem J       Date:  1993-09

6.  Role of neutrophils in breakdown of the blood-retinal barrier following intravitreal injection of platelet-activating factor.

Authors:  D Smith; E K Lee; P Saloupis; J K Davis; D L Hatchell
Journal:  Exp Eye Res       Date:  1994-10       Impact factor: 3.467

7.  Interleukin-1 alpha, interleukin-1 beta, and tumor necrosis factor gene expression in endotoxin-induced uveitis.

Authors:  M Yoshida; N Yoshimura; M Hangai; H Tanihara; Y Honda
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-03       Impact factor: 4.799

8.  Mediators of the ocular inflammatory response to interleukin-1 beta plus tumor necrosis factor-alpha.

Authors:  L Fleisher; J Ferrell; C McGahan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-02       Impact factor: 3.117

9.  Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha.

Authors:  L Claudio; J A Martiney; C F Brosnan
Journal:  Lab Invest       Date:  1994-06       Impact factor: 5.662

10.  Role of eicosanoids but not nitric oxide in the platelet-activating factor-induced increase in vascular permeability in mouse skin.

Authors:  E Fujii; K Irie; Y Uchida; K Ohba; T Muraki
Journal:  Eur J Pharmacol       Date:  1995-02-06       Impact factor: 4.432
View more
  22 in total

Review 1.  Spare the rod and spoil the eye.

Authors:  G B Arden; R L Sidman; W Arap; R O Schlingemann
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

2.  Chronic macular edema associated with extrafoveal vitreoretinal traction.

Authors:  Aaron Trevino; Michael R Martinez; Avinoam Ophir
Journal:  Int J Ophthalmol       Date:  2010-12-18       Impact factor: 1.779

3.  Intravitreal infliximab for refractory pseudophakic cystoid macular edema: results of the Pan-American Collaborative Retina Study Group.

Authors:  Lihteh Wu; J Fernando Arevalo; Erick Hernandez-Bogantes; José A Roca
Journal:  Int Ophthalmol       Date:  2012-04-08       Impact factor: 2.031

4.  Comparison of the efficacy between an intravitreal and a posterior subtenon injection of triamcinolone acetonide for the treatment of diffuse diabetic macular edema.

Authors:  Rao Muhammad Rashad Qamar; Muhammad Imran Saleem; Muhammad Farhan Saleem
Journal:  Eurasian J Med       Date:  2013-10

5.  Involvement of A(1) adenosine receptors in osmotic volume regulation of retinal glial cells in mice.

Authors:  Antje Wurm; Stephan Lipp; Thomas Pannicke; Regina Linnertz; Katrin Färber; Peter Wiedemann; Andreas Reichenbach; Andreas Bringmann
Journal:  Mol Vis       Date:  2009-09-12       Impact factor: 2.367

6.  Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil.

Authors:  Piergiorgio Neri; Cesare Mariotti; Luca Cimino; Lucia Mercanti; Alfonso Giovannini
Journal:  Int Ophthalmol       Date:  2008-02-23       Impact factor: 2.031

7.  Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown.

Authors:  Virginia Haurigot; Pilar Villacampa; Albert Ribera; Cristina Llombart; Assumpcio Bosch; Victor Nacher; David Ramos; Eduard Ayuso; José C Segovia; Juan A Bueren; Jesus Ruberte; Fatima Bosch
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

Review 8.  Vascular endothelial growth factor in eye disease.

Authors:  J S Penn; A Madan; R B Caldwell; M Bartoli; R W Caldwell; M E Hartnett
Journal:  Prog Retin Eye Res       Date:  2008-05-28       Impact factor: 21.198

9.  Real-world outcomes following 12 months of intravitreal aflibercept monotherapy in patients with diabetic macular edema in France: results from the APOLLON study.

Authors:  Jean-François Korobelnik; Vincent Daien; Céline Faure; Ramin Tadayoni; Audrey Giocanti-Auregan; Corinne Dot; Laurent Kodjikian; Pascale Massin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-02       Impact factor: 3.117

10.  Combined vitrectomy and intravitreal injection versus combined laser and injection for treatment of intractable diffuse diabetic macular edema.

Authors:  Ahmed M Saeed
Journal:  Clin Ophthalmol       Date:  2013-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.